Using PROMIS® to create clinically meaningful profiles of nephrotic syndrome patients

Jonathan P. Troost; Debbie S. Gipson; Noelle E. Carlozzi; Bryce B. Reeve; Patrick H. Nachman; Rasheed Gbadegesin; Jichuan Wang; Frank Modersitzki; Susan Massengill; John D. Mahan; Yang Liu; Howard Trachtman; Emily G. Herreshoff; Darren A. Dewalt; David T. Selewski

doi:10.1037/hea0000679

Using PROMIS® to create clinically meaningful profiles of nephrotic syndrome patients

Jonathan P. Troost, Debbie S. Gipson, Noelle E. Carlozzi, Bryce B. Reeve, Patrick H. Nachman, Rasheed Gbadegesin, Jichuan Wang, Frank Modersitzki, Susan Massengill, John D. Mahan, Yang Liu, Howard Trachtman, Emily G. Herreshoff, Darren A. Dewalt, David T. Selewski

Medicine - Renal and Hypertension Division

Research output: Contribution to journal › Article › peer-review

15 Scopus citations

Abstract

Objective: Nephrotic syndrome (NS) is a kidney disease known to adversely impact health-related quality of life (HRQOL). Patient-reported outcome (PRO) measures are commonly used to characterize HRQOL and the patient disease experience. This study aims to improve the interpretability and clinical utility of the Patient Reported Outcomes Measurement Information System® (PROMIS®) by identifying distinct meaningful HRQOL profiles in children and adults with NS. Method: Patients were from 2 prospective NS cohort studies (PROMIS-II®: 121 children; NEPTUNE: 40 children and 219 adults) with data from 6 PROMIS® domains. Latent Profile Analysis was used to identify subgroups of patients based on PROMIS® score patterns. A 3-step analysis of latent profile predictors was used to determine how clinical parameters predicted HRQOL profile membership. Results: We identified 3 HRQOL profiles (Good, Average, and Poor) with strong indicators of membership classification (entropy 0.86). Complete proteinuria remission, reduction in symptoms, and shorter disease duration, were significant predictors of better HRQOL profile membership. Conclusions: Patients with NS can be classified by HRQOL into clinically meaningful categories. Integrating this approach into clinic may help in the identification of individuals with poor HRQOL will help clinicians better manage their symptoms and researchers study the causes and possible interventions for these patients. PROMIS® HRQOL profiles were reproducible in replication cohorts.

Original language	English (US)
Pages (from-to)	410-421
Number of pages	12
Journal	Health Psychology
Volume	38
Issue number	5
DOIs	https://doi.org/10.1037/hea0000679
State	Published - May 2019

Bibliographical note

Funding Information:
The Nephrotic Syndrome Study Network Consortium (NEPTUNE) U54-DK-083912 is a part of the National Center for Advancing Translational Sciences (NCATS) Rare Disease Clinical Research Network (RDCRN), supported through a collaboration between the Office of Rare Diseases Research (ORDR), NCATS, and the National Institute of Diabetes, Digestive, and Kidney Diseases. RDCRN is an initiative of ORDR, NCATS. Additional funding and/or programmatic support for this project has also been provided by the University of Michigan, NephCure Kidney International, and the Halpin Foundation.

Funding Information:
PROMIS® was funded with cooperative agreements from the National Institutes of Health (NIH) Common Fund Initiative (Northwestern University, PI: David Cella, U54AR057951, U01AR052177; Northwestern University, PI: Richard C. Gershon, U54AR057943; American Institutes for Research, PI: Susan (San) D. Keller, U54AR057926; State University of New York, Stony Brook, PIs: Joan E. Broderick, and Arthur A. Stone, U01AR057948, U01AR052170; University of Washington, Seattle, PIs: Heidi M. Crane, Paul K. Crane, MPH, and Donald L. Patrick, U01AR057954; University of Washington, Seattle, PI: Dagmar Amtmann, U01AR052171; University of North Carolina at Chapel Hill, PI: Harry A. Guess, (deceased), Darren A. DeWalt, U01AR052181; Children’s Hospital of Philadelphia, PI: Christopher B. Forrest, U01AR057956; Stanford University, PI: James F. Fries, U01AR052158; Boston University, PIs: Alan Jette, Stephen M. Haley, (deceased), and David Scott Tulsky, (University of Michigan), U01AR057929; University of California, Los Angeles, PIs: Dinesh Khanna, (University of Michigan) and Brennan Spiegel,

Publisher Copyright:
© 2019 American Psychological Association.

Keywords

Latent profile analysis
Nephrology
Nephrotic syndrome
PROMIS®
Pediatrics
Quality of life

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1037/hea0000679

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6499490

OpenUrl availability

Full text

Cite this

Troost, J. P., Gipson, D. S., Carlozzi, N. E., Reeve, B. B., Nachman, P. H., Gbadegesin, R., Wang, J., Modersitzki, F., Massengill, S., Mahan, J. D., Liu, Y., Trachtman, H., Herreshoff, E. G., Dewalt, D. A., & Selewski, D. T. (2019). Using PROMIS® to create clinically meaningful profiles of nephrotic syndrome patients. Health Psychology, 38(5), 410-421. https://doi.org/10.1037/hea0000679

Troost, JP, Gipson, DS, Carlozzi, NE, Reeve, BB, Nachman, PH, Gbadegesin, R, Wang, J, Modersitzki, F, Massengill, S, Mahan, JD, Liu, Y, Trachtman, H, Herreshoff, EG, Dewalt, DA & Selewski, DT 2019, 'Using PROMIS® to create clinically meaningful profiles of nephrotic syndrome patients', Health Psychology, vol. 38, no. 5, pp. 410-421. https://doi.org/10.1037/hea0000679

@article{4a3274c96ec14f409a2800ce96dfd313,

title = "Using PROMIS{\textregistered} to create clinically meaningful profiles of nephrotic syndrome patients",

abstract = "Objective: Nephrotic syndrome (NS) is a kidney disease known to adversely impact health-related quality of life (HRQOL). Patient-reported outcome (PRO) measures are commonly used to characterize HRQOL and the patient disease experience. This study aims to improve the interpretability and clinical utility of the Patient Reported Outcomes Measurement Information System{\textregistered} (PROMIS{\textregistered}) by identifying distinct meaningful HRQOL profiles in children and adults with NS. Method: Patients were from 2 prospective NS cohort studies (PROMIS-II{\textregistered}: 121 children; NEPTUNE: 40 children and 219 adults) with data from 6 PROMIS{\textregistered} domains. Latent Profile Analysis was used to identify subgroups of patients based on PROMIS{\textregistered} score patterns. A 3-step analysis of latent profile predictors was used to determine how clinical parameters predicted HRQOL profile membership. Results: We identified 3 HRQOL profiles (Good, Average, and Poor) with strong indicators of membership classification (entropy 0.86). Complete proteinuria remission, reduction in symptoms, and shorter disease duration, were significant predictors of better HRQOL profile membership. Conclusions: Patients with NS can be classified by HRQOL into clinically meaningful categories. Integrating this approach into clinic may help in the identification of individuals with poor HRQOL will help clinicians better manage their symptoms and researchers study the causes and possible interventions for these patients. PROMIS{\textregistered} HRQOL profiles were reproducible in replication cohorts.",

keywords = "Latent profile analysis, Nephrology, Nephrotic syndrome, PROMIS{\textregistered}, Pediatrics, Quality of life",

author = "Troost, {Jonathan P.} and Gipson, {Debbie S.} and Carlozzi, {Noelle E.} and Reeve, {Bryce B.} and Nachman, {Patrick H.} and Rasheed Gbadegesin and Jichuan Wang and Frank Modersitzki and Susan Massengill and Mahan, {John D.} and Yang Liu and Howard Trachtman and Herreshoff, {Emily G.} and Dewalt, {Darren A.} and Selewski, {David T.}",

note = "Funding Information: The Nephrotic Syndrome Study Network Consortium (NEPTUNE) U54-DK-083912 is a part of the National Center for Advancing Translational Sciences (NCATS) Rare Disease Clinical Research Network (RDCRN), supported through a collaboration between the Office of Rare Diseases Research (ORDR), NCATS, and the National Institute of Diabetes, Digestive, and Kidney Diseases. RDCRN is an initiative of ORDR, NCATS. Additional funding and/or programmatic support for this project has also been provided by the University of Michigan, NephCure Kidney International, and the Halpin Foundation. Funding Information: PROMIS{\textregistered} was funded with cooperative agreements from the National Institutes of Health (NIH) Common Fund Initiative (Northwestern University, PI: David Cella, U54AR057951, U01AR052177; Northwestern University, PI: Richard C. Gershon, U54AR057943; American Institutes for Research, PI: Susan (San) D. Keller, U54AR057926; State University of New York, Stony Brook, PIs: Joan E. Broderick, and Arthur A. Stone, U01AR057948, U01AR052170; University of Washington, Seattle, PIs: Heidi M. Crane, Paul K. Crane, MPH, and Donald L. Patrick, U01AR057954; University of Washington, Seattle, PI: Dagmar Amtmann, U01AR052171; University of North Carolina at Chapel Hill, PI: Harry A. Guess, (deceased), Darren A. DeWalt, U01AR052181; Children{\textquoteright}s Hospital of Philadelphia, PI: Christopher B. Forrest, U01AR057956; Stanford University, PI: James F. Fries, U01AR052158; Boston University, PIs: Alan Jette, Stephen M. Haley, (deceased), and David Scott Tulsky, (University of Michigan), U01AR057929; University of California, Los Angeles, PIs: Dinesh Khanna, (University of Michigan) and Brennan Spiegel, Publisher Copyright: {\textcopyright} 2019 American Psychological Association.",

year = "2019",

month = may,

doi = "10.1037/hea0000679",

language = "English (US)",

volume = "38",

pages = "410--421",

journal = "Health Psychology",

issn = "0278-6133",

publisher = "American Psychological Association",

number = "5",

}

TY - JOUR

T1 - Using PROMIS® to create clinically meaningful profiles of nephrotic syndrome patients

AU - Troost, Jonathan P.

AU - Gipson, Debbie S.

AU - Carlozzi, Noelle E.

AU - Reeve, Bryce B.

AU - Nachman, Patrick H.

AU - Gbadegesin, Rasheed

AU - Wang, Jichuan

AU - Modersitzki, Frank

AU - Massengill, Susan

AU - Mahan, John D.

AU - Liu, Yang

AU - Trachtman, Howard

AU - Herreshoff, Emily G.

AU - Dewalt, Darren A.

AU - Selewski, David T.

N1 - Funding Information: The Nephrotic Syndrome Study Network Consortium (NEPTUNE) U54-DK-083912 is a part of the National Center for Advancing Translational Sciences (NCATS) Rare Disease Clinical Research Network (RDCRN), supported through a collaboration between the Office of Rare Diseases Research (ORDR), NCATS, and the National Institute of Diabetes, Digestive, and Kidney Diseases. RDCRN is an initiative of ORDR, NCATS. Additional funding and/or programmatic support for this project has also been provided by the University of Michigan, NephCure Kidney International, and the Halpin Foundation. Funding Information: PROMIS® was funded with cooperative agreements from the National Institutes of Health (NIH) Common Fund Initiative (Northwestern University, PI: David Cella, U54AR057951, U01AR052177; Northwestern University, PI: Richard C. Gershon, U54AR057943; American Institutes for Research, PI: Susan (San) D. Keller, U54AR057926; State University of New York, Stony Brook, PIs: Joan E. Broderick, and Arthur A. Stone, U01AR057948, U01AR052170; University of Washington, Seattle, PIs: Heidi M. Crane, Paul K. Crane, MPH, and Donald L. Patrick, U01AR057954; University of Washington, Seattle, PI: Dagmar Amtmann, U01AR052171; University of North Carolina at Chapel Hill, PI: Harry A. Guess, (deceased), Darren A. DeWalt, U01AR052181; Children’s Hospital of Philadelphia, PI: Christopher B. Forrest, U01AR057956; Stanford University, PI: James F. Fries, U01AR052158; Boston University, PIs: Alan Jette, Stephen M. Haley, (deceased), and David Scott Tulsky, (University of Michigan), U01AR057929; University of California, Los Angeles, PIs: Dinesh Khanna, (University of Michigan) and Brennan Spiegel, Publisher Copyright: © 2019 American Psychological Association.

PY - 2019/5

Y1 - 2019/5

N2 - Objective: Nephrotic syndrome (NS) is a kidney disease known to adversely impact health-related quality of life (HRQOL). Patient-reported outcome (PRO) measures are commonly used to characterize HRQOL and the patient disease experience. This study aims to improve the interpretability and clinical utility of the Patient Reported Outcomes Measurement Information System® (PROMIS®) by identifying distinct meaningful HRQOL profiles in children and adults with NS. Method: Patients were from 2 prospective NS cohort studies (PROMIS-II®: 121 children; NEPTUNE: 40 children and 219 adults) with data from 6 PROMIS® domains. Latent Profile Analysis was used to identify subgroups of patients based on PROMIS® score patterns. A 3-step analysis of latent profile predictors was used to determine how clinical parameters predicted HRQOL profile membership. Results: We identified 3 HRQOL profiles (Good, Average, and Poor) with strong indicators of membership classification (entropy 0.86). Complete proteinuria remission, reduction in symptoms, and shorter disease duration, were significant predictors of better HRQOL profile membership. Conclusions: Patients with NS can be classified by HRQOL into clinically meaningful categories. Integrating this approach into clinic may help in the identification of individuals with poor HRQOL will help clinicians better manage their symptoms and researchers study the causes and possible interventions for these patients. PROMIS® HRQOL profiles were reproducible in replication cohorts.

AB - Objective: Nephrotic syndrome (NS) is a kidney disease known to adversely impact health-related quality of life (HRQOL). Patient-reported outcome (PRO) measures are commonly used to characterize HRQOL and the patient disease experience. This study aims to improve the interpretability and clinical utility of the Patient Reported Outcomes Measurement Information System® (PROMIS®) by identifying distinct meaningful HRQOL profiles in children and adults with NS. Method: Patients were from 2 prospective NS cohort studies (PROMIS-II®: 121 children; NEPTUNE: 40 children and 219 adults) with data from 6 PROMIS® domains. Latent Profile Analysis was used to identify subgroups of patients based on PROMIS® score patterns. A 3-step analysis of latent profile predictors was used to determine how clinical parameters predicted HRQOL profile membership. Results: We identified 3 HRQOL profiles (Good, Average, and Poor) with strong indicators of membership classification (entropy 0.86). Complete proteinuria remission, reduction in symptoms, and shorter disease duration, were significant predictors of better HRQOL profile membership. Conclusions: Patients with NS can be classified by HRQOL into clinically meaningful categories. Integrating this approach into clinic may help in the identification of individuals with poor HRQOL will help clinicians better manage their symptoms and researchers study the causes and possible interventions for these patients. PROMIS® HRQOL profiles were reproducible in replication cohorts.

KW - Latent profile analysis

KW - Nephrology

KW - Nephrotic syndrome

KW - PROMIS®

KW - Pediatrics

KW - Quality of life

UR - http://www.scopus.com/inward/record.url?scp=85065144542&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065144542&partnerID=8YFLogxK

U2 - 10.1037/hea0000679

DO - 10.1037/hea0000679

M3 - Article

C2 - 31045424

AN - SCOPUS:85065144542

SN - 0278-6133

VL - 38

SP - 410

EP - 421

JO - Health Psychology

JF - Health Psychology

IS - 5

ER -

Using PROMIS® to create clinically meaningful profiles of nephrotic syndrome patients

Abstract

Bibliographical note

Keywords

UN SDGs

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this